Add BrightSurf on Google Email

Adverse drug reactions may be under-reported in young children

A new study reveals that spontaneous reports of adverse drug reactions in newborns and infants are insufficient, highlighting the need for additional reporting strategies. The UK's Yellow Card Scheme, established over 50 years ago, has improved drug safety but may not be enough to capture all instances of adverse reactions.

SourceWiley·JournalBritish Journal of Clinical Pharmacology·DateSep 7, 2016

Over-the-counter head lice treatments are likely to fail

A recent review found that over-the-counter head lice treatments have declined in effectiveness, likely due to widespread use leading to pyrethroid resistance. Prescription products such as malathion and spinosad are safer alternatives with proven efficacy.

SourceWiley·JournalPediatric Dermatology·DateSep 6, 2016

Warts and all: How St. John's Wort can make you sick

Researchers found that St John's Wort produces the same adverse reactions as antidepressants, including anxiety, panic attacks, and dizziness. The study highlights the need for people to seek advice from qualified healthcare practitioners when using herbal medicines like St John's Wort.

SourceUniversity of Adelaide·JournalClinical and Experimental Pharmacology and Physiology·DateJul 1, 2015

Understanding statin discontinuation

A study by Brigham and Women's Hospital found that over 90% of patients who stopped taking statins due to adverse reactions were able to tolerate them again. The researchers examined clinical data from over 107,835 patients and identified a pattern where most people who experienced symptoms or events related to the drug stopped taking ...

SourceBrigham and Women's Hospital·JournalAnnals of Internal Medicine·DateApr 1, 2013

Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients

A new study published in the Journal of Rheumatology shows that KRYSTEXXA significantly improves pain, physical function, and health-related quality of life in adult patients with refractory chronic gout. The treatment resulted in clinically meaningful improvements in these areas compared to placebo.

SourceBurns McClellan·JournalThe Journal of Rheumatology·DateJul 2, 2012

Frailty not a factor in adverse drug reactions among seniors, study finds

A recent study published in the Journal of the American Geriatrics Society found no association between frailty and an increased risk of adverse drug reactions among elderly patients. Instead, researchers discovered that the greatest risk factor for adverse reactions was the number of new medications recently added to a patient's regimen.

SourceUniversity of California - San Francisco·JournalJournal of the American Geriatrics Society·DateApr 6, 2011

Study shows a serious risk of side effects when having latent tuberculosis therapy over age 65

A new study published in CMAJ found that people over 65 undergoing latent tuberculosis infection therapy are at a higher risk of severe adverse reactions requiring hospitalization. The study provides age-stratified estimates of the risk of these events, accounting for comorbidities and similar health events in the general population.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateJan 10, 2011

Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests

A recent study published in the American Journal of Roentgenology found that acute adverse reactions from gadolinium-based contrast agents used during MRI are rare, occurring in only 0.16 percent of all administrations. The majority of reactions were mild, while six moderate and two severe reactions were reported.

SourceAmerican College of Radiology·JournalAmerican Journal of Roentgenology·DateJan 21, 2010

Is 4 agents decoction efficacious in treating primary dysmenorrhea?

A Taiwanese study suggests that Four-Agents Decoction, an 800-year-old traditional Chinese herbal formula, may exhibit a beneficial effect on primary dysmenorrhea after extended treatment. However, the study did not detect significant pain reduction in the initial cycle. The authors recommend further research with larger sample sizes a...

SourcePLOS·JournalPLOS ONE·DateAug 21, 2007

Study compares efficacy and adherence to triple nucleoside therapy Ziagen + Combivir with protease inhibitor plus Combivir regimens in therapy-nave

A study found that 74% of patients taking Ziagen/Combivir had viral loads below 400 copies/ml at 24 weeks, compared to 57% on the PI-containing regimen. Patients on Ziagen/Combivir also reported fewer difficulties with their triple regimen. The study assessed efficacy, safety, and patient adherence in therapy-naive patients.